Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, April 26, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matt Miksic Maintained (BSX) at Buy with Increased Target to $78 on, Apr 26th, 2024
Matt Miksic of Barclays, Maintained "Boston Scientific Corporation" (BSX) at Buy with Increased Target from $70 to $78 on, Apr 26th, 2024.
Matt has made no other calls on BSX in the last 4 months.
There are 15 other peers that have a rating on BSX. Out of the 15 peers that are also analyzing BSX, 2 agree with Matt's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Pito Chickering of "Deutsche Bank" Maintained at Hold with Increased Target to $73 on, Thursday, April 25th, 2024
- Steven Lichtman of "Oppenheimer" Maintained at Hold with Increased Target to $68 on, Thursday, February 1st, 2024
These are the ratings of the 13 analyists that currently disagree with Matt
- Anthony Petrone of "Mizuho" Maintained at Strong Buy with Increased Target to $85 on, Thursday, April 25th, 2024
- Danielle Antalffy of "UBS" Maintained at Strong Buy with Increased Target to $90 on, Thursday, April 25th, 2024
- David Rescott of "Baird" Maintained at Buy with Increased Target to $84 on, Thursday, April 25th, 2024
- Jayson Bedford of "Raymond James" Maintained at Strong Buy with Increased Target to $85 on, Thursday, April 25th, 2024
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $85 on, Thursday, April 25th, 2024
- Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $82 on, Thursday, April 25th, 2024
- Shagun Singh of "RBC Capital" Maintained at Buy with Increased Target to $82 on, Thursday, April 25th, 2024
- Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $82 on, Thursday, April 25th, 2024
- Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Increased Target to $78 on, Thursday, April 25th, 2024
- Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $82 on, Wednesday, April 24th, 2024
- John Eade of "Argus Research" Maintained at Strong Buy with Increased Target to $80 on, Wednesday, April 3rd, 2024
- Joshua Jennings of "TD Cowen" Maintained at Buy with Increased Target to $77 on, Thursday, March 7th, 2024
- Marie Thibault of "BTIG" Reiterated at Strong Buy and Held Target at $64 on, Friday, December 29th, 2023
Contributing Sources
- D885FD0B-4D59-419D-81DE-3DF4BF5AB503
- support@woprai.com
WOPRAI
- Barclays
Matt Miksic